Home › Vaso-Occlusive Crises › Washington
Vaso-Occlusive Crises clinical trials in Washington, DC
3 studies for Vaso-Occlusive Crises are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
RecruitingPhase 3
- Childrens National Hospital, Washington D.C.
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
RecruitingPhase 2
- Center for Cancer and Blood Disorders, Bethesda · 7 mi away
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
RecruitingPhase 2
- Medstar Washington Hospital Center, Washington D.C.
Vaso-Occlusive Crises trials in other cities
Other studies in Washington
- Cancer (all types)60 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer44 studies
- Metastatic Cancer44 studies
- Lung Cancer41 studies
- Prostate Cancer39 studies
- Obesity34 studies
- Colorectal Cancer28 studies
- Cardiovascular Disease27 studies
- Bladder Cancer26 studies
- Ovarian Cancer25 studies
- Lymphoma23 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.